Lv1
90 积分 2026-05-07 加入
Tirzepatide cardiovascular event risk assessment: a pre-specified meta-analysis
1天前
已完结
Efficacy and safety of tirzepatide added to basal insulin in patients with type 2 diabetes in China (SURPASS-CN-INS): a double-blind, multicentre, randomised, placebo-controlled, phase 3 trial. The Lancet Diabetes & Endocrinology
1天前
已关闭
Lixin Guo, et al., (2025). Efficacy and safety of tirzepatide added to basal insulin in patients with type 2 diabetes in China (SURPASS-CN-INS): a double-blind, multicentre, randomised, placebo-controlled, phase 3 trial. The Lancet Diabetes & Endocrinology
1天前
已关闭
Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021
2天前
已完结
Statins aggravate insulin resistance through reduced blood glucagon-like peptide-1 levels in a microbiota-dependent manner
20天前
已完结
Effects of statin therapy on diagnoses of new-onset diabetes and worsening glycaemia in large-scale randomised blinded statin trials: an individual participant data meta-analysis
21天前
已完结
Comparison of the efficacy and safety of GLP-1 receptor agonists on cardiovascular events and risk factors: A review and network meta-analysis
24天前
已完结
Semaglutide and blood pressure: an individual patient data meta-analysis
24天前
已完结
Effects of tirzepatide on the clinical trajectory of patients with heart failure, preserved ejection fraction, and obesity
1个月前
已完结
Perioperative dapagliflozin in diabetic patients undergoing cardiac surgery: the DAPA-CS trial
1个月前
已完结
皖公网安备34019202002308
